Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Actinic Keratosis Treatment Market: By Therapy: Topical, Surgery, Photodynamic Therapy; By Drug Class: Nucleoside Metabolic Inhibitors, Nonsteroidal Anti-Inflammatory Drugs, Others; By End Use; Regional Analysis; Historical Market and Forecast (2017-2027); Competitive Landscape; Industry Events and Developments

Global Actinic Keratosis Treatment Market Outlook

The global actinic keratosis treatment market attained nearly USD 6.5 billion in 2020 and is expected to grow at a CAGR of 4.2% over the forecast period.

 

The increased prevalence of actinic keratosis, driven by environmental factors such as the depletion of ozone and prolonged sun exposure, is the major factor driving the growth of the actinic keratosis treatment industry globally.

 

Actinic Keratosis Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

Actinic keratosis refers to the growth of scaly patch on skin that grows out of years of sun exposure. Chances of its occurrence are more in people who are exposed to sunlight, and, thus, are at higher risk of actinic keratosis. The growth of actinic keratosis could lead to squamous cell carcinoma, which is a type of cancer.

 

Actinic Keratosis Treatment Market by therapy

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF


 
The global actinic keratosis treatment industry can be broadly categorised based on segments like therapy, drug class, end-uses, and regions.

  • Therapy:
    • Topical
    • Surgery
    • Photodynamic Therapy
  • Drug Class:
    • Nucleoside Metabolic Inhibitors
    • Nonsteroidal Anti-Inflammatory Drugs
    • Immune Response Modifiers
    • Photoenhancers
    • Others
  • End-Use:
    • Hospitals
    • Private Clinics
    • Homecare
    • Others

The EMR report looks into the regional actinic keratosis treatment markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific

 

Actinic Keratosis Treatment Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

It is projected that the increasing prevalence of actinic keratosis, the rising acceptance of minimally invasive therapeutic procedures, the availability of appropriate medical coverage, and a growing geriatric population are the major drivers of the market growth. However, the risk factors associated with available treatment options may hamper industry growth over the forecast period.

The hospitals segment, among other end uses, dominates the industry owing to the ease of accessibility, rise in healthcare infrastructure, and the growing number of patients.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global actinic keratosis treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Bausch Health Companies Inc.
  • LEO Pharma A/S
  • Almirall, S.A
  • Biofrontera
  • Hill Dermaceuticals, Inc.
  • Others

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Therapy, Drug Class, End Use, Region
Breakup by Therapy Topical, Surgery, Photodynamic Therapy
Breakup by Drug Class Nucleoside Metabolic Inhibitors, Nonsteroidal Anti-Inflammatory Drugs, Immune Response Modifiers, Photoenhancers, Others
Breakup by End Use Hospitals, Private Clinics, Homecare, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Bausch Health Companies Inc., LEO Pharma A/S, Almirall, S.A, Biofrontera, Hill Dermaceuticals, Inc., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Actinic Keratosis Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Actinic Keratosis Treatment Historical Market (2017-2021) 
    8.3    Global Actinic Keratosis Treatment Market Forecast (2022-2027)
    8.4    Global Actinic Keratosis Treatment Market by Therapy
        8.4.1    Topical
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Surgery
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Photodynamic Therapy
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
    8.5    Global Actinic Keratosis Treatment Market by Drug Class
        8.5.1    Nucleoside Metabolic Inhibitors
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Nonsteroidal Anti-Inflammatory Drugs
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Immune Response Modifiers
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Photoenhancers
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2017-2021)
            8.5.4.3    Forecast Trend (2022-2027)
        8.5.5    Others
    8.6    Global Actinic Keratosis Treatment Market by End Use
        8.6.1    Hospitals
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Private Clinics
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Homecare
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
        8.6.4    Others
    8.7    Global Actinic Keratosis Treatment Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Bausch Health Companies Inc.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    LEO Pharma A/S
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Almirall, S.A
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Biofrontera
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Hill Dermaceuticals, Inc.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments


List of Figures and Tables

1.    Global Actinic Keratosis Treatment Market: Key Industry Highlights, 2016 and 2026
2.    Global Actinic Keratosis Treatment Historical Market: Breakup by Therapy (USD Billion), 2017-2021
3.    Global Actinic Keratosis Treatment Market Forecast: Breakup by Therapy (USD Billion), 2022-2027
4.    Global Actinic Keratosis Treatment Historical Market: Breakup by Drug Class (USD Billion), 2017-2021
5.    Global Actinic Keratosis Treatment Market Forecast: Breakup by Drug Class (USD Billion), 2022-2027
6.    Global Actinic Keratosis Treatment Historical Market: Breakup by End Use (USD Billion), 2017-2021
7.    Global Actinic Keratosis Treatment Market Forecast: Breakup by End Use (USD Billion), 2022-2027
8.    Global Actinic Keratosis Treatment Historical Market: Breakup by Region (USD Billion), 2017-2021
9.    Global Actinic Keratosis Treatment Market Forecast: Breakup by Region (USD Billion), 2022-2027
10.    North America Actinic Keratosis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
11.    North America Actinic Keratosis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
12.    Europe Actinic Keratosis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
13.    Europe Actinic Keratosis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
14.    Asia Pacific Actinic Keratosis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
15.    Asia Pacific Actinic Keratosis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
16.    Latin America Actinic Keratosis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
17.    Latin America Actinic Keratosis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
18.    Middle East and Africa Actinic Keratosis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
19.    Middle East and Africa Actinic Keratosis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
20.    Global Actinic Keratosis Treatment Market Structure

Key Questions Answered in the Report

In 2020, the global actinic keratosis treatment market attained a value of nearly USD 6.5 billion.

The market is projected to grow at a CAGR of 4.2% between 2021 and 2026.

The major drivers of the market include the increasing prevalence of actinic keratosis, growing acceptance of minimally invasive therapeutic procedures, and increasing geriatric population.

Depletion of ozone layer leading to an increased incidence of actinic keratosis is the key industry trend propelling the growth of the market.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The leading therapies of actinic keratosis treatment in the market are topical, surgery, and photodynamic therapy.

The major drug classes of actinic keratosis treatment in the industry are nucleoside metabolic inhibitors, nonsteroidal anti-inflammatory drugs, immune response modifiers, and photoenhancers, among others.

The significant end use sectors of actinic keratosis treatment in the market are hospitals, private clinics, and homecare, among others.

The major players in the industry are Bausch Health Companies Inc., LEO Pharma A/S, Almirall, S.A., Biofrontera, and Hill Dermaceuticals Inc., among others.

Analyst Review

The global actinic keratosis treatment market attained a value of USD 6.5 billion in 2020, driven by the increasing prevalence of actinic keratosis. Aided by the rising implementation of favourable medical coverage, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 4.2%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on therapy, the actinic keratosis treatment industry can be segmented into topical, surgery, and photodynamic therapy. On the basis of drug class, the actinic keratosis treatment industry is divided into nucleoside metabolic inhibitors, nonsteroidal anti-inflammatory drugs, immune response modifiers, photoenhancers, and others. The industry can be classified based on end use into hospitals, private clinics, homecare, and others. The major regional markets for actinic keratosis treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Bausch Health Companies Inc., LEO Pharma A/S, Almirall, S.A., Biofrontera, Hill Dermaceuticals Inc., and others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER